HLS Therapeutics Inc.
OTC: HLTRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Craig Stuart Millian
- Employees
- 92
- Headquarters
- Etobicoke, Canada
- IPO year
- 2010
- Market cap
- $98.8M
- Website
- https://www.hlstherapeutics.com
Loading HLTRF…
Loading profile data…Frequently asked questions about HLTRF
What does HLS Therapeutics Inc. (HLTRF) do?
HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiovascular (CV) therapeutic areas. The company's activities extend across Canada, the United States, and international territories. Its core product li...
Where does HLTRF trade?
HLS Therapeutics Inc. (HLTRF) trades on the Other OTC.
What sector is HLTRF in?
HLS Therapeutics Inc. (HLTRF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of HLS Therapeutics Inc.?
Craig Stuart Millian is the chief executive officer of HLS Therapeutics Inc. (HLTRF).
Where is HLS Therapeutics Inc. headquartered?
HLS Therapeutics Inc. is headquartered in Canada.
Does HLTRF pay a dividend?
HLS Therapeutics Inc. (HLTRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HLTRF go public?
HLS Therapeutics Inc. (HLTRF) completed its initial public offering in 2010.